Endovascular Aneurysm Repair (EVAR) Market Set for Rapid Growth and Trend, by 2026
Aortic
aneurysm is a medical condition, in which aorta, gets enlarged.
Abdominal and Thoracic are two categories of aortic aneurysm. These
conditions can lead to abdominal pain, low blood pressure, loss of
consciousness or even death. Endovascular
aneurysm repair (EVAR) is a minimally invasive surgical
method to treat abdominal and thoracic aortic aneurysm. It is an
alternative to open surgery for abdominal aortic aneurysm (AAA),
which makes it relatively safe and less time consuming. However, not
all patients suffering from aneurysm are suitable for EVAR. Also, it
is difficult to treat aneurysm near or on the kidney using EVAR.
Endovascular
Aneurysm Repair (EVAR) Market Taxonomy:
By
Product Type
-
Fenestrated Stent Graft
-
Adjunctive Stent Graft
-
Branched Stent Graft
-
Others
By
Indication
-
Abdominal Aortic Aneurysm (AAA)
-
Thoracic Aortic aneurysm (TAA)
-
Descending Aortic Aneurysm
-
Ascending Aortic Aneurysm
By
End Users
-
Hospitals
-
Ambulatory care services
-
Specialty clinics
By
Geography
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East
-
Africa
North
America Is Expected To Hold A Dominant Position In Global
Endovascular Aneurysm Repair (Evar) Market Over The Forecast Period:
North
America accounted for the largest share in the global endovascular
aneurysm market in 2016, owing to increasing prevalence of aneurysms
and rising geriatric population, which is more prone to this
condition. According to the New England Journal of Medicine, 2016,
278,921 patients underwent repair of abdominal aortic aneurysm in the
U.S. during 2005–2012. According to Centers for Disease Control and
Prevention (CDC), in 2014, aortic aneurysms led to death of 9,863 in
the U.S. Moreover, aneurysm is more prevalent is geriatric population
i.e. 50 years and above. According to the U.S. Population Reference
Bureau, the population aged 65 years and above is expected to
increase from 46 million in 2014 to over 98 million by 2060. With
increasing geriatric population, prevalence of aneurysm is also
expected to increase. Europe is expected to be the second largest
market for EVAR. This is owing to implementation of the National
Health Service program across the U.K. This involves screening for
various disease conditions among the populace in the region.
Successful implementation of this system has in turn led to fast
detection of abdominal aneurysm especially in the U.K., Italy, and
Sweden. This helps in early diagnosis of disease, thereby, increasing
demand for AAA treatments such as EVAR.
Request
For Customization of Research Report
@https://www.coherentmarketinsights.com/insight/request-customization/1339
Global
Key Players:
Key
players operating in endovascular aneurysm market include
Medtronic
plc. Cook Medical, Gore Medical, B. Braun Melsungen AG, Terumo
Corporation, Boston Scientific Corporation, Abbott Laboratories,
Volcano Corporation, C.R. Bard, Spectranetics International BV,
Cordis Corporation (Johnson and Johnson Co.), and St. Jude Medical
Inc.
About
Coherent Market Insights
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us
Mr.
Shah
Coherent
Market Insights
1001
4th Ave, #3200
Seattle,
WA 98154
Tel:
+1-206-701-6702

Comments
Post a Comment